These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 15885994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
    Smesny S, Klemm S, Stockebrand M, Grunwald S, Gerhard UJ, Rosburg T, Sauer H, Blanz B.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
    [Abstract] [Full Text] [Related]

  • 3. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A, Giacometti J, Nadalin S, Rubesa G, Vulin M, Tomljanović D.
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [Abstract] [Full Text] [Related]

  • 4. Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder.
    Smesny S, Baur K, Rudolph N, Nenadic I, Sauer H.
    J Affect Disord; 2010 Aug; 124(3):335-40. PubMed ID: 20116108
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
    Smesny S, Rosburg T, Baur K, Rudolph N, Sauer H.
    Neuropsychopharmacology; 2007 Oct; 32(10):2067-73. PubMed ID: 17314920
    [Abstract] [Full Text] [Related]

  • 7. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
    Liu CM, Chang SS, Liao SC, Hwang TJ, Shieh MH, Liu SK, Chen WJ, Hwu HG.
    Psychiatry Res; 2007 Aug 30; 152(2-3):181-7. PubMed ID: 17459487
    [Abstract] [Full Text] [Related]

  • 8. The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia.
    Smesny S, Rosburg T, Klemm S, Riemann S, Baur K, Rudolph N, Grunwald S, Sauer H.
    J Psychiatr Res; 2004 Aug 30; 38(5):537-43. PubMed ID: 15380405
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis.
    Maclean R, Ward PE, Glen I, Roberts SJ, Ross BM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep 30; 27(6):927-33. PubMed ID: 14499309
    [Abstract] [Full Text] [Related]

  • 13. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
    Messamore E, Hoffman WF, Janowsky A.
    Schizophr Res; 2003 Aug 01; 62(3):251-8. PubMed ID: 12837522
    [Abstract] [Full Text] [Related]

  • 14. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
    Messamore E.
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec 01; 69(6):413-9. PubMed ID: 14623495
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Negative correlation between cerebral inorganic phosphate and the volumetric niacin response in male patients with schizophrenia who have seriously and dangerously violently offended: a (31)P magnetic resonance spectroscopy study.
    Puri BK, Richardson AJ, Counsell SJ, Ward PE, Bustos MG, Hamilton G, Bhakoo KK, Treasaden IH.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug 01; 77(2):97-9. PubMed ID: 17765531
    [Abstract] [Full Text] [Related]

  • 17. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
    Messamore E, Hoffman WF, Yao JK.
    Schizophr Res; 2010 Sep 01; 122(1-3):248-56. PubMed ID: 20417059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.
    Yao JK, Dougherty GG, Gautier CH, Haas GL, Condray R, Kasckow JW, Kisslinger BL, Gurklis JA, Messamore E.
    Schizophr Bull; 2016 Mar 01; 42(2):369-76. PubMed ID: 26371338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.